Prepare for the 2024-25 respiratory illness season

As the 2024-25 respiratory illness season approaches, communities across the region are bracing for the challenges posed by COVID-19, influenza and respiratory syncytial virus (RSV). With updated vaccines and new recommendations in place, individuals are encouraged take proactive steps to protect themselves and their loved ones against these respiratory illnesses.

Dr. Michael Walters, Aspirus senior vice president and system chief medical officer, emphasized the importance of vaccination in maintaining community health.

“Vaccination remains our most effective tool in preventing severe illness, hospitalizations and complications associated with COVID-19, influenza and RSV,” he said. “We strongly urge everyone eligible to get vaccinated this season.”

Updated COVID-19 vaccines

With recent FDA approval, updated COVID-19 vaccines are becoming available at area vaccination providers. These vaccines have been specifically designed to enhance protection against the evolving virus during the upcoming season. The Centers for Disease Control and Prevention (CDC) recommends that all individuals aged 6 months and older receive a seasonal COVID-19 vaccine.

“Staying up to date with COVID-19 vaccinations is crucial,” Walters said. “These updated vaccines are tailored to the latest strains, ensuring that you have the best possible protection as we enter the peak respiratory illness season.”

Influenza vaccination

For the 2024-25 influenza season, trivalent vaccines will be used, tailored to address the strains expected to circulate this year. The CDC advises everyone aged 6 months and older to get their annual flu shot to reduce the risk of severe illness and complications.

“Influenza can be just as dangerous as COVID-19, particularly for vulnerable populations,” said Walters. “Annual flu vaccination is essential to keeping our communities healthy and reducing the burden on our health care system.”

RSV protection for vulnerable populations

In response to increasing awareness and the need for protection against RSV, the CDC has expanded its vaccination recommendations. These include:

• Pregnant women: To help protect newborns, pregnant women are encouraged to receive the RSV vaccine.

• Older adults: Individuals aged 75 and older, as well as those aged 60-74 with heightened risk factors for severe RSV disease, should be vaccinated.

• Infants: RSV immunization with monoclonal antibodies is recommended for the infants younger than 8 months, particularly those born just before or during the RSV season, and infants aged 8-19 months who are at increased risk for severe RSV disease and are entering their second RSV season.

“RSV poses a significant risk to both the very young and the elderly,” Walters said. “We are committed to ensuring that these vulnerable populations have access to the necessary vaccinations to stay protected this season.”

For reliable and up-to-date information about COVID-19, influenza and RSV vaccinations, the public is encouraged to visit trusted resources such as the CDC website or consult with their health care provider.